Crossmark

Reduced relapse rate and improved GVHD/relapse free survival (GRFS) with pharmacokinetics-guided busulfan conditioning regimen for allogeneic stem cell transplantation in adult patients with myeloid hematologic malignancies

Crossref DOI link: https://doi.org/10.1038/s41409-026-02826-z

Published Online: 2026-03-29

Published Print: 2026-05

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Mariotti, Jacopo https://orcid.org/0000-0001-6528-9296
De Philippis, Chiara https://orcid.org/0000-0002-7738-997X
De Gregori, Simona https://orcid.org/0000-0002-9627-8730
Giordano, Laura

Tentori, Cristina

Taurino, Daniela

Sarina, Barbara

Mannina, Daniele https://orcid.org/0000-0002-1378-6896
Capone, Mara

Giacomel, Arianna

Santoro, Armando

Bramanti, Stefania
License Information

Text and Data Mining valid from 2026-03-29

Version of Record valid from 2026-03-29
More Information

Article History

Received: 19 December 2025

Revised: 6 February 2026

Accepted: 9 March 2026

First Online: 29 March 2026

Competing interests

: The authors declare no competing interests.

: The study was conducted in accordance with the Declaration of Helsinki and approved by the Institutional Review Board of the Humanitas Cancer Institute.

: Informed consent was obtained from all subjects involved in the study.

Document is current

Any future updates will be listed below